Inpharmatica
Curated by SignalDeveloper of predictive informatics based platform for drug discovery
Overview
Inpharmatica has developed a platform that uses predictive informatics in medicinal chemistry and ADME for drug discovery. The Chemagenomics platform is used for in silico target selection through drug assessment and identification of leads. The company also offers another platform called Silico used for ADME optimization, in silicon and in vitro assessments for identifying leads from hits.
Key facts
- Founded
- 1998
- Headquarters
- London, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 8 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view